Clinical management potential tumours of low malignancy.
about
Fertility sparing treatment in borderline ovarian tumoursFertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistryPhase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours.Conserving fertility in the management of gynaecological cancers.Risk factors for recurrence of ovarian borderline tumors.Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.Borderline tumours of the ovary, current controversies regarding their diagnosis and treatmentOvarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.Clinical management of borderline ovarian tumors.Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.Ovarian epithelial tumors and reproductive factors: a systematic review.Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.Short-term Outcomes and Pregnancy Rate After Laparoscopic Fertility-Sparing Surgery for Borderline Ovarian Tumors: A Single-Institute Experience.Management of Borderline Ovarian Tumors-Still a Gray Zone.
P2860
Q28081482-E1B89072-C18D-45D1-9003-0998A16EE869Q34317865-AC61B5E6-3814-4A2C-B08A-31EE468340FDQ34442933-77FB55E2-68AA-44F5-8142-7CF3614CED0CQ35628323-D14AC51F-15A5-4669-B4C0-EC63EBF2619EQ36367795-82870200-0331-4B87-AA22-95E09DB2B076Q36830662-C198D029-BF41-4B5E-8A62-6CABCE7F4196Q37350421-4AC8D0F5-3F7B-4429-845C-0B285EB211A7Q37406768-D8A968BE-0668-4A30-81DA-E375F2EE34FDQ37632101-C527BD86-FF98-4886-9E7C-8798FB882A3DQ37774358-0F524DE2-E1D2-4598-A282-8775D02F354BQ37801854-311AE75E-ACBC-4A23-B308-7B2050AD6C82Q38090489-993D20C4-EFD0-42E2-80F1-8D40649E9EE9Q38333986-EE47D809-0D3C-483B-BC81-76AF24D382CCQ38694178-8A490A2A-894F-4B31-AB56-BFE91B2CEFF2Q44690616-71EF6B1A-DCF1-4CC6-80F3-B66FE0499063Q49317200-AD48CBCA-6CBD-41F5-8E92-8D7A953E2485Q50080187-98CCD7B3-0A3F-4CC4-B963-403B14AAE448
P2860
Clinical management potential tumours of low malignancy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical management potential tumours of low malignancy.
@ast
Clinical management potential tumours of low malignancy.
@en
Clinical management potential tumours of low malignancy.
@nl
type
label
Clinical management potential tumours of low malignancy.
@ast
Clinical management potential tumours of low malignancy.
@en
Clinical management potential tumours of low malignancy.
@nl
prefLabel
Clinical management potential tumours of low malignancy.
@ast
Clinical management potential tumours of low malignancy.
@en
Clinical management potential tumours of low malignancy.
@nl
P356
P1476
Clinical management potential tumours of low malignancy.
@en
P2093
David M Gershenson
P304
P356
10.1053/BEOG.2002.0308
P577
2002-08-01T00:00:00Z